Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial

1. Richmond, P.C.
2. Marshall, H.S.
3. Nissen, M.D.
4. Jiang, Q.
5. Jansen, K.U.
6. Garcés-Sánchez, M.
7. Martinón-Torres, F.
8. Beeslaar, J.
9. Szenborn, L.
10. Wysocki, J.
11. Eiden, J.
12. Harris, S.L.
13. Jones, T.R.
14. Perez, J.L.